Evidence map›Paper›PMID 42593899›Full record

ArticleJournal of medicinal chemistry2026

Structure-Activity Relationship Study of Protoberberine Alkaloids Reveals Molecular Planarity as a Key Determinant of Membrane Interaction and Protection from Misfolded Protein Oligomers.

Silvia Errico, Alessandra Bigi, Giulia Fani, Monica Ambrosino, Erwan Galmiche, Francesco Bemporad, Michele Vendruscolo, Benedetta Mannini, Fabrizio Chiti

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Silvia ErricoDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence50134, Italy.ORCID 0000-0001-6197-9740
Alessandra BigiDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence50134, Italy.ORCID 0000-0002-1067-6288
Giulia FaniDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence50134, Italy.
Monica AmbrosinoDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence50134, Italy.
Erwan GalmicheDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence50134, Italy.
Francesco BemporadDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence50134, Italy.
Michele VendruscoloCentre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, CambridgeCB2 1EW, U.K.ORCID 0000-0002-3616-1610
Benedetta ManniniDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence50134, Italy.ORCID 0000-0001-6812-7348
Fabrizio ChitiDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence50134, Italy.ORCID 0000-0002-1330-1289

Funding

MIUR-Italy NAProgetto Dipartimenti di Eccellenza 2022-2027 NAUniversity of Florence (Fondi di Ateneo) NA
6 · The paper itself

Abstract

Interaction of berberine (Brb) with cell membranes is crucial for its bioavailability, blood-brain barrier permeation, and neuroprotection against misfolded protein oligomers in neurodegenerative diseases. Although Brb follows Lipinski's rule of five, the structural drivers of its membrane permeation remain unclear. We combined biophysical analyses on biomimetic liposomes with cell culture assays to evaluate eight natural protoberberine alkaloids (PBAs), assessing membrane interactions and protective effects. While traditional physicochemical descriptors varied minimally across the series, molecular planarity, quantified by non-hydrogen out-of-plane atoms, emerged as the key structural feature determining membrane binding affinity, kinetics, stiffening, and protein-oligomer displacement. These membrane effects correlated with the ability of the compounds to mitigate oligomer-induced calcium influx in cell cultures, an early cytotoxicity marker. ANS fluorescence and circular dichroism spectroscopy showed no direct oligomer-PBA interaction, ruling out this mechanism. These findings establish a rational framework for optimizing the Brb benzylisoquinoline scaffold, indicating that increasing molecular planarity enhances membrane affinity and neuroprotection.

Indexed as

Berberine AlkaloidsCell MembraneAnimalsCalciumHumansProtein FoldingStructure-Activity RelationshipBerberine AlkaloidsCalciumprotoberberine

Identifiers

PMID42593899
PMCPMC13492292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.